- Global Pharma News & Resources

C-Reactive Protein Testing Market surpassed USD 5.6 Bn in 2021, owing to growing occurrences of noncommunicable diseases such as cardiovascular diseases | insightSLICE

The global C-Reactive Protein Testing market size was estimated to be US$ 5.6 billion in 2021 and is expected grow at a CAGR of 1.1% between 2023 to 2032.

In the report on the C-Reactive Protein Testing Market, we discuss the trends and analyses of the global market with a prediction for 2022–2032.

In addition to taking into account the competitive climate, the forecast study will contain a summary of the key players in the worldwide in vitro fertilization (IVF) market along with their market projections.

Access the sample report:

The report would also cover notable developments, regional and global sales subsidiaries, corporate strategies, R&D projects, staff size, and chief employees for all leading market participants.

For example, the Life Sciences business section of Danaher Corporation accounted for the majority of the firm’s USD 17,911.1 million in sales in 2019, according to the company’s study of its product segments.

The key players of the Global C-Reactive Protein Testing Market are:

Abbott Laboratories, Abaxis, Inc., Aidian, Danaher Corporation, F. Hoffmann-La Roche Ltd., BODITECH MED INC., HORIBA, Ltd., Laboratory Corporation of America Holdings, Getein Biotech, Inc., Quest Diagnostics Incorporated, Merck KGaA, Ortho Clinical Diagnostics, Siemens, Randox Laboratories Ltd., and Thermo Fisher Scientific, Inc. are significant market participants in the C-reactive protein testing market.

Key factors and reasons for the growth of this market:

The global c-reactive protein market size was estimated to be US$ 5.6 billion in 2021 and is expected grow at a CAGR of 1.1% between 2023 to 2032.

The main drivers of the market expansion for C-reactive protein testing are the incidence of cardiovascular diseases, the requirement for complex diagnostic procedures, and rising investment in clinical diagnosis.

C protein functions in attaching to the lysophosphatidylcholine on the surface of dead or dying cells and is generally detected in the bloodstream. An increase in blood C-protein causes inflammation and serves as a warning sign for infections or cardiovascular problems.

When patients are admitted to the hospital or facility for treating an infectious disease or a cardiovascular issue, a C-reactive protein test is specifically performed to diagnose the inflammation rate. This test aids in simplifying the necessary treatments and procedures.

Read more about the report inclusions:

According to American Heart Association figures from 2019, there are about 350,000 cases of cardiac arrest outside of a hospital each year in the country. Because of this, healthcare authorities are concentrating on setting up point-of-care testing units to check blood levels of C-reactive protein.

Amid the rise in cardiovascular and cancer rates worldwide, the global C-reactive protein market is predicted to have a considerable increase during the forecast period.

Statistics covered in our report:

The report will determine the firm segment concentrating on C-reactive protein testing products and technologies as well as provide an in-depth analysis of key companies holding the largest share of the worldwide market with a focus on all operating business segments.

Mentioned in this report would be the market shares of well-known businesses operating in the global market for C-reactive protein testing. As an illustration, Danaher Corporation operates its company through three divisions that are the life science division, the diagnostics division, and environmental & applied technologies.

The Life Science commercial area of the corporation provides C-reactive protein diagnostic products and technologies, contributing US$ 7.0 billion in revenue in 2019.

All of the C-reactive protein testing product and technology strategies, product portfolios, significant developments, SWOT analyses, and R&D priorities are taken into account in the study.

The companies involved in the market’s distribution chain and cost structure, as well as their contributions, will be examined in this research on the global C-reactive protein testing market. All of the commodities in the company’s C-reactive protein testing business sector would be the main focus of the core businesses and product line sector.

Similar to this, the portion of the current development would concentrate on the most recent corporate activities, including growth strategies, mergers and acquisitions, the introduction of new products, and alliances and collaborations in the global market for C-reactive protein testing.

Related reports:

Global Endodontic Consumables Market:

Global Diagnostic Electrocardiograph (ECG) Market:

Global C-Reactive Protein Testing Market Key Segments:

By Assay Type

  • Immunoturbidimetric method
  • Enzyme-Linked Immunosorbent Assay ELISA
    • Clinical
    • Non-clinical
  • Chemiluminescence immunoassay
  • Others

By Detection Range

  • hs- CRP
  • Conventional CRP
  • cCRP

By Disease Area

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

By End Use

  • Clinics
  • Hospitals
  • Research Laboratories
  • Home Care Settings
  • Others

By Geography:

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Regional performance of C-Reactive Protein Testing Market

Currently, the North American region accounted for the highest share of the global market for C-reactive protein testing, and it is expected to continue to hold this position throughout the projected timeline.

Cardiovascular illnesses’ incidence and growth, cancer incidence, and rising R&D spending are the main drivers of the C-reactive protein testing market’s demand and economic expansion in North America.

Because of the increasing prevalence of cardiovascular, inflammatory bowel disease, and people with cancer, Asia Pacific is predicted to be the most attractive market throughout the projection period.

During the forecast period, increased investment in sophisticated testing technology research and development and growing healthcare infrastructure are anticipated to boost the Asia Pacific C-reactive protein testing market.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 28-Nov-2022